FDA approves hydroxychloroquine new drug application to address COVID-19 related shortage

The FDA has approved an abbreviated new drug application for hydroxychloroquine sulfate tablets to address ongoing shortages of the drug sparked by its still unproven potential as a COVID-19 treatment. The application, submitted by Accord Healthcare, was approved on April 7. The approved indications are uncomplicated malaria due to […]

Click here to view original web page at www.healio.com

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.